Beneficial effects of arginase inhibition and inhaled l-arginine administration on airway histology in a murine model of chronic asthma

Allergologia et Immunopathologia

Volumn 42, Issue 4, 2014, Pages 316-323

  Arikan Ayyildiz, Z ^a   Karaman, M ^a   Tuncel, T ^a   Kiray, M ^a   Bagriyanik A ^a   Yilmaz, O ^a   Uzuner, N ^a   Karaman, Ö ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Arginase inhibition; Asthma; L Arginine; Murine model; Nor NOHA

Indexed keywords

ARGINASE; ARGININE; BUDESONIDE; ENZYME INHIBITOR; INTERLEUKIN 4; INTERLEUKIN 5; N OMEGA HYDROXY NOR LEVO ARGININE; PLACEBO; UNCLASSIFIED DRUG; ANTIASTHMATIC AGENT; N(OMEGA)-HYDROXYNORARGININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; ENZYME INHIBITION; EOSINOPHIL; HISTOLOGY; LUNG HOMOGENATE; LUNG LAVAGE; MALE; MONOTHERAPY; MOUSE; NONHUMAN; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHRONIC DISEASE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG; PATHOLOGY;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-ASTHMATIC AGENTS; ARGINASE; ARGININE; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; INFLAMMATION; LUNG; MALE; MICE; MICE, INBRED BALB C;

EID: 84903816796     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2013.01.001     Document Type: Article

References (29)

1. Ricciardolo F.L., Sterk P.J., Gaston B., Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004, 84:731-765.
2. Maarsingh H., Zaagsma J., Meurs H. Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 2009, 158:652-654.
3. Hamid Q., Springall D.R., Riveros-Moreno V., Chanez P., Howarth P., Redington A., et al. Induction of nitric oxide synthase in asthma. Lancet 1993, 342:1510-1513.
4. Crino G., Fiorucci S., Sessa W.C. Endothelial nitric oxide synthase: the Cinderalla of inflammation. Trends Pharmacol Sci 2003, 24:91-95.
5. De Boer J., Meurs H., Flendrig L., Kopal M., Zaagsma J. Role of nitric oxide and superoxide in allergen induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br J Pharmacol 2001, 133:1235-1242.
6. Xia Y., Zweier J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997, 94:6954-6958.
7. Xia Y., Roman L.J., Masters B.S., Zweier J.L. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem 1998, 273:22635-22639.
8. Meurs H., McKay S., Maarsingh H., Hamer M.A., Macic L., Molendijk N., et al. Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002, 136:391-398.
9. Zimmermann N., King N.E., Laporte J., Yang M., Mishra A., Pope S.M., et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003, 111:1863-1874.
10. Morris C.R., Poljakovic M., Lavrisha L., Machado L., Kuypers F.A., Morris S.M. Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004, 170:148-153.
11. Lara A., Khatri S.B., Wang Z., Comhair S.A., Xu W., Dweik R.A., et al. National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med 2008, 178:673-681.
12. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., Kumar R.K. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998, 53:849-856.
13. Olmez D., Babayigit A., Uzuner N., Erbil G., Karaman O., Yilmaz O., et al. Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma. Exp Lung Res 2008, 34:501-511.
14. Maarsingh H., Zuidhof A.B., Bos I.S., van Duin M., Boucher J.L., Zaagsma J., et al. Arginase inhibiton protects against allergen-induced airway obstruction, hyperresponsiveness and inflammation. Am J Respir Crit Care Med 2008, 178:565-573.
15. Gong P.H., Gao Z.C., Hu P., Xu Y. Investigation of the measurement of murine airway hyperresponsiveness and the therapeutic effects of budesonide on ovalbumin sensitized and challenged mice. Chin Med J (Engl) 2005, 118:1959-1964.
16. Topal G., Brunet A., Walch L., Boucher J.L., David-Dufilho M. Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable l-arginine pools in human endothelial cells. J Pharmacol Exp Ther 2006, 318:1368-1374.
17. Frank M.P., Powers R.W. Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids. J Chromatogr B: Anal Technol Biomed Life Sci 2007, 852:646-649.
18. 15N] nitrite in biological fluids. Anal Biochem 1982, 126:131-138.
19. Appleton J. Arginine: clinical potential of a semi-essential amino. Altern Med Rev 2002, 7:512-522.
20. Takano H., Lim H.B., Miyabara Y., Ichinose T., Yoshikawa T., Sagai M. Oral admisitration of l-arginine potentiates allergen induced airway inflammation and expression of interleukin-5 in mice. J Pharmacol Exp Ther 1998, 286:767-771.
21. Qadi-Nassar B.A., Laurent-Bichon F., Portet K., Tramini P., Arnoux B., Michel A. Effects of l-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responiseveness of sensitized BP2 mice. Clin Pharmacol 2007, 21:611-620.
22. De Gouw H.W., Verbruggen M.B., Twiss I.M., Sterk P.J. Effect of oral l-arginine on airway hyperresponsiveness to histamine in asthma. Thorax 1999, 54:1033-1035.
23. Sapienza M.A., Khaeitonov S.A., Horvath I., Chung K.F., Barnes P.J. Effect of inhaled l-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax 1998, 53:1033-1035.
24. Abuzayan I., Turner S.W. Changes in exhaled nitric oxide after ingestion of l-arginine in children: a pilot study. Pediatr Pulmonol 2010, 45:236-240.
25. Mabalirajan U., Ahmad T., Leishangthem G.D., Dinda A.K., Agrawal A., Ghosh B. l-Arginine reduces mitochondrial dysfunction and airway injury in murine allergic airway inflammation. Int Immunopharmacol 2010, 10:1514-1519.
26. Mabalirajan U., Ahmad T., Leishangthem G.D., Joseph D.A., Dinda A.K., Agrawal A., et al. Beneficial effects of high dose of l-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma. J Allergy Clin Immunol 2010, 125:626-635.
27. Bratt J.M., Franzi L.M., Linderholm A.L., Last M.S., Kenyon N.J., Last J.A. Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol 2009, 234:273-280.
28. Ckless K., Lampert A., Reiss J., Kasahara D., Poynter M.E., Irvin C.G., et al. Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol 2008, 181:4255-4264.
29. Bratt J.M., Franzi L.M., Linderholm A.L., O'Roark E.M., Kenyon N.J., Last J.A. Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. Toxicol Appl Pharmacol 2010, 242:1-8.